Aethlon Medical, Inc.

NasdaqCM:AEMD Stock Report

Market Cap: US$11.2m

Aethlon Medical Management

Management criteria checks 4/4

Aethlon Medical's CEO is Jim Frakes, appointed in Jan 2008, has a tenure of 1.17 years. total yearly compensation is $416.45K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.017% of the company’s shares, worth $1.90K. The average tenure of the management team and the board of directors is 4 years and 7.2 years respectively.

Key information

Jim Frakes

Chief executive officer

US$416.4k

Total compensation

CEO salary percentage100.0%
CEO tenure17yrs
CEO ownership0.02%
Management average tenure4yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

Aug 02
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

FDA approves protocol change in Aethlon's trial of its purifier to treat severe COVID

Jul 11

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

Mar 18
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow

Nov 09
We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow

Aethlon Medical climbs on Reddit interest

Jun 09

We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

May 12
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate

We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely

Jan 27
We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely

Aethlon Medical has a new business and medical chief

Jan 06

Aethlon Medical (AEMD) rockets 63% as FDA amends Hemopurifier IDE for COVID-10 treatment

Dec 16

Aethlon names Charles J. Fisher, Jr., M.D. as CEO

Nov 03

CEO Compensation Analysis

How has Jim Frakes's remuneration changed compared to Aethlon Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$11m

Jun 30 2024n/an/a

-US$11m

Mar 31 2024US$416kUS$416k

-US$12m

Dec 31 2023n/an/a

-US$12m

Sep 30 2023n/an/a

-US$12m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022n/an/a

-US$13m

Sep 30 2022n/an/a

-US$13m

Jun 30 2022n/an/a

-US$11m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021n/an/a

-US$9m

Sep 30 2021n/an/a

-US$9m

Jun 30 2021n/an/a

-US$9m

Mar 31 2021US$582kUS$275k

-US$8m

Dec 31 2020n/an/a

-US$7m

Sep 30 2020n/an/a

-US$6m

Jun 30 2020n/an/a

-US$6m

Mar 31 2020US$355kUS$264k

-US$6m

Dec 31 2019n/an/a

-US$6m

Sep 30 2019n/an/a

-US$7m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019US$286kUS$256k

-US$6m

Dec 31 2018n/an/a

-US$6m

Sep 30 2018n/an/a

-US$5m

Jun 30 2018n/an/a

-US$5m

Mar 31 2018US$235kUS$235k

-US$6m

Compensation vs Market: Jim's total compensation ($USD416.45K) is below average for companies of similar size in the US market ($USD642.68K).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.

CEO

Jim Frakes (67 yo)

17yrs

Tenure

US$416,449

Compensation

Mr. James B. Frakes, also known as Jim, M.B.A. has been the Chief Financial Officer at Aethlon Medical, Inc. since January 2008 and served as its Interim Chief Executive Officer since November 07, 2023 unt...

Leadership Team

NamePositionTenureCompensationOwnership
James Frakes
CEO, CFO17yrsUS$416.45k0.017%
$ 1.9k
Guy Cipriani
Senior VP & COO1.2yrsUS$378.06k0.013%
$ 1.4k
Steven LaRosa
Chief Medical Officer4yrsUS$430.00k0%
$ 0

4.0yrs

Average Tenure

56yo

Average Age

Experienced Management: AEMD's management team is considered experienced (4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
James Frakes
CEO, CFO1.2yrsUS$416.45k0.017%
$ 1.9k
Edward Broenniman
Independent Chairman of the Board25.8yrsUS$147.50k0.18%
$ 20.6k
Nathan Levin
Member of Extracorporeal Therapy Advisory Boardno datano datano data
Gregory T. Kovacs
Member of Extracorporeal Therapy Advisory Boardno datano datano data
Claudio Ronco
Member of Extracorporeal Therapy Advisory Boardno datano datano data
Larry Cowgill
Member of Sepsis & Inflammation Advisory Boardno datano datano data
John Kellum
Member of Extracorporeal Therapy Advisory Boardno datano datano data
Chetan Shah
Independent Director11.6yrsUS$113.75k0.15%
$ 17.2k
David Ward
Member of Extracorporeal Therapy Advisory Boardno datano datano data
Irshad Chaudry
Member of Sepsis & Inflammation Advisory Boardno datano datano data
Geert Schmid-Schönbein
Member of Sepsis & Inflammation Advisory Boardno datano datano data
Angela Rossetti
Independent Director2.8yrsUS$113.00k0.18%
$ 20.0k

7.2yrs

Average Tenure

69yo

Average Age

Experienced Board: AEMD's board of directors are considered experienced (7.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 09:33
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aethlon Medical, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vernon BernardinoH.C. Wainwright & Co.
Anthony VendettiMaxim Group
Ajay TandonSeeThruEquity, LLC